Outcomes with porcine graft placement in the anterior vaginal compartment in patients who undergo high vaginal uterosacral suspension and cystocele repair

Thomas L. Wheeler, Holly E. Richter, Angela G. Duke, Kathryn L. Burgio, David T. Redden, R. Edward Varner

Research output: Contribution to journalArticle

41 Citations (Scopus)

Abstract

Objective: The purpose of this study was to prospectively assess the cases of patients who had undergone a high uterosacral suspension and anterior repair with anterior compartment placement of porcine dermis graft. Study design: Thirty-six patients who underwent transvaginal high uterosacral suspension and cystocele repair with graft augmentation from June 2001 to July 2004 were identified from the University of Alabama at Birmingham Genitourinary Disorders database. Analysis included the pre- and postoperative Pelvic Organ Prolapse Quantification examinations and incontinence impact questionnaire-7/urogenital distress inventory-6. Results: Mean Pelvic Organ Prolapse Quantification Ba improved from +3.3 ± 2.2 cm to -0.6 ± 1.7 cm (P < .01). Postoperative Ba was prolapse stage II or greater in 50% of subjects. Mean incontinence impact questionnaire-7 scores improved from 36.2 ± 31.9 to 15.6 ± 26.2 (P < .01), as did mean urogenital distress inventory-6 scores from 58.2 ± 26.8 to 23.8 ± 22.6 (P < .01). Conclusion: Significant improvements in Pelvic Organ Prolapse Quantification measures, urinary symptoms, and the impact of incontinence were seen after the operation. However, a significant proportion of patients had Pelvic Organ Prolapse Quantification stage II prolapse or greater, which made it unclear whether graft use confers a significant advantage.

Original languageEnglish (US)
Pages (from-to)1486-1491
Number of pages6
JournalAmerican journal of obstetrics and gynecology
Volume194
Issue number5
DOIs
StatePublished - May 1 2006

Fingerprint

Cystocele
Pelvic Organ Prolapse
Suspensions
Swine
Transplants
Prolapse
Equipment and Supplies
Dermis
Databases

Keywords

  • Cystocele
  • Outcome
  • Uterosacral suspension
  • Xenograft

ASJC Scopus subject areas

  • Obstetrics and Gynecology

Cite this

Outcomes with porcine graft placement in the anterior vaginal compartment in patients who undergo high vaginal uterosacral suspension and cystocele repair. / Wheeler, Thomas L.; Richter, Holly E.; Duke, Angela G.; Burgio, Kathryn L.; Redden, David T.; Varner, R. Edward.

In: American journal of obstetrics and gynecology, Vol. 194, No. 5, 01.05.2006, p. 1486-1491.

Research output: Contribution to journalArticle

Wheeler, Thomas L. ; Richter, Holly E. ; Duke, Angela G. ; Burgio, Kathryn L. ; Redden, David T. ; Varner, R. Edward. / Outcomes with porcine graft placement in the anterior vaginal compartment in patients who undergo high vaginal uterosacral suspension and cystocele repair. In: American journal of obstetrics and gynecology. 2006 ; Vol. 194, No. 5. pp. 1486-1491.
@article{5bf4050e4c644246855220eff08a1b2a,
title = "Outcomes with porcine graft placement in the anterior vaginal compartment in patients who undergo high vaginal uterosacral suspension and cystocele repair",
abstract = "Objective: The purpose of this study was to prospectively assess the cases of patients who had undergone a high uterosacral suspension and anterior repair with anterior compartment placement of porcine dermis graft. Study design: Thirty-six patients who underwent transvaginal high uterosacral suspension and cystocele repair with graft augmentation from June 2001 to July 2004 were identified from the University of Alabama at Birmingham Genitourinary Disorders database. Analysis included the pre- and postoperative Pelvic Organ Prolapse Quantification examinations and incontinence impact questionnaire-7/urogenital distress inventory-6. Results: Mean Pelvic Organ Prolapse Quantification Ba improved from +3.3 ± 2.2 cm to -0.6 ± 1.7 cm (P < .01). Postoperative Ba was prolapse stage II or greater in 50{\%} of subjects. Mean incontinence impact questionnaire-7 scores improved from 36.2 ± 31.9 to 15.6 ± 26.2 (P < .01), as did mean urogenital distress inventory-6 scores from 58.2 ± 26.8 to 23.8 ± 22.6 (P < .01). Conclusion: Significant improvements in Pelvic Organ Prolapse Quantification measures, urinary symptoms, and the impact of incontinence were seen after the operation. However, a significant proportion of patients had Pelvic Organ Prolapse Quantification stage II prolapse or greater, which made it unclear whether graft use confers a significant advantage.",
keywords = "Cystocele, Outcome, Uterosacral suspension, Xenograft",
author = "Wheeler, {Thomas L.} and Richter, {Holly E.} and Duke, {Angela G.} and Burgio, {Kathryn L.} and Redden, {David T.} and Varner, {R. Edward}",
year = "2006",
month = "5",
day = "1",
doi = "10.1016/j.ajog.2006.01.075",
language = "English (US)",
volume = "194",
pages = "1486--1491",
journal = "American Journal of Obstetrics and Gynecology",
issn = "0002-9378",
publisher = "Mosby Inc.",
number = "5",

}

TY - JOUR

T1 - Outcomes with porcine graft placement in the anterior vaginal compartment in patients who undergo high vaginal uterosacral suspension and cystocele repair

AU - Wheeler, Thomas L.

AU - Richter, Holly E.

AU - Duke, Angela G.

AU - Burgio, Kathryn L.

AU - Redden, David T.

AU - Varner, R. Edward

PY - 2006/5/1

Y1 - 2006/5/1

N2 - Objective: The purpose of this study was to prospectively assess the cases of patients who had undergone a high uterosacral suspension and anterior repair with anterior compartment placement of porcine dermis graft. Study design: Thirty-six patients who underwent transvaginal high uterosacral suspension and cystocele repair with graft augmentation from June 2001 to July 2004 were identified from the University of Alabama at Birmingham Genitourinary Disorders database. Analysis included the pre- and postoperative Pelvic Organ Prolapse Quantification examinations and incontinence impact questionnaire-7/urogenital distress inventory-6. Results: Mean Pelvic Organ Prolapse Quantification Ba improved from +3.3 ± 2.2 cm to -0.6 ± 1.7 cm (P < .01). Postoperative Ba was prolapse stage II or greater in 50% of subjects. Mean incontinence impact questionnaire-7 scores improved from 36.2 ± 31.9 to 15.6 ± 26.2 (P < .01), as did mean urogenital distress inventory-6 scores from 58.2 ± 26.8 to 23.8 ± 22.6 (P < .01). Conclusion: Significant improvements in Pelvic Organ Prolapse Quantification measures, urinary symptoms, and the impact of incontinence were seen after the operation. However, a significant proportion of patients had Pelvic Organ Prolapse Quantification stage II prolapse or greater, which made it unclear whether graft use confers a significant advantage.

AB - Objective: The purpose of this study was to prospectively assess the cases of patients who had undergone a high uterosacral suspension and anterior repair with anterior compartment placement of porcine dermis graft. Study design: Thirty-six patients who underwent transvaginal high uterosacral suspension and cystocele repair with graft augmentation from June 2001 to July 2004 were identified from the University of Alabama at Birmingham Genitourinary Disorders database. Analysis included the pre- and postoperative Pelvic Organ Prolapse Quantification examinations and incontinence impact questionnaire-7/urogenital distress inventory-6. Results: Mean Pelvic Organ Prolapse Quantification Ba improved from +3.3 ± 2.2 cm to -0.6 ± 1.7 cm (P < .01). Postoperative Ba was prolapse stage II or greater in 50% of subjects. Mean incontinence impact questionnaire-7 scores improved from 36.2 ± 31.9 to 15.6 ± 26.2 (P < .01), as did mean urogenital distress inventory-6 scores from 58.2 ± 26.8 to 23.8 ± 22.6 (P < .01). Conclusion: Significant improvements in Pelvic Organ Prolapse Quantification measures, urinary symptoms, and the impact of incontinence were seen after the operation. However, a significant proportion of patients had Pelvic Organ Prolapse Quantification stage II prolapse or greater, which made it unclear whether graft use confers a significant advantage.

KW - Cystocele

KW - Outcome

KW - Uterosacral suspension

KW - Xenograft

UR - http://www.scopus.com/inward/record.url?scp=33646096964&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33646096964&partnerID=8YFLogxK

U2 - 10.1016/j.ajog.2006.01.075

DO - 10.1016/j.ajog.2006.01.075

M3 - Article

C2 - 16647932

AN - SCOPUS:33646096964

VL - 194

SP - 1486

EP - 1491

JO - American Journal of Obstetrics and Gynecology

JF - American Journal of Obstetrics and Gynecology

SN - 0002-9378

IS - 5

ER -